Since 2008, we have founded and built 9 life science companies, a portfolio that is comprised of both established industry leaders and soon-to-be-known successes. With multiple patents, our companies have an aggregate market value of more than $400 million and have provided a 10x return to our early investors. And we are only getting started.
Medgenome is being India’s leading genomic diagnostics and research company which leverages South Asia’s unique founder populations to discover better diagnostics, screening tests and novel drug targets that address significant unmet needs across global markets.
Awarded MedTech Breakthrough award for biomedical research in 2018.